Company Overview and News
Companies operating in the U.S. meat and poultry manufacturing space are in dire straits, thanks to concerns surrounding high input costs, soft demand and volatility induced by an unstable tariff environment. While few companies are managing to survive such difficulties on brand strength and savings efforts, others like Sanderson Farms, Inc (SAFM - Free Report) are struggling to stay afloat. This renowned chicken products company’s shares tanked around 29.
HRL TSNU SAFM TSN
Hormel Foods Corporation (HRL - Free Report) unveiled plans to expand Burke manufacturing facility through investments worth almost $150 million. Notably, Burke, located in Nevada, is one of the leading manufacturers of pizza toppings and other fully-cooked meat products in the prepared food and foodservice arena. Burke Expansion Likely to Strengthen Brands Hormel Foods’ latest expansion initiative is one of its major ventures.
IPAR HRL DANOY GPN CHEF
43 of 53 S&P 500 Dividend Aristocrats stocks were deemed "safer" for dividends because they showed positive one-year returns and free cash flow yields greater than their dividend yields.
GD APD KMB NUE WMT HRL SWK PEP CINF CVX ITW BEN ABBV CLX ABBV LEG
After a sideways range between $100-$110 during the first half of 2018, McCormick (NYSE:MKC), a Fortune 1000 company by revenue, finally broke through $110 in early July and closed at $132.29 on Friday, Sept. 14. Despite the recent impressive run-up in the stock price, I expect the uptrend to continue and there are several long strategies in McCormick stock that could lead to impressive profits.
INGR HRL SJM MKC KHC IFF
After a difficult 2018, investors may consider adding Tyson Foods (NYSE:TSN) stock to their portfolio for the rest of the year. There are several long strategies in TSN stock that could lead to impressive profits.
HRL TSNU IBA SAFM TSN PPC
2018-09-14 seekingalpha - 2
San Miguel (OTCPK:SMGBY) has seen its stock price surge further on details of the IPO for its food and beverage business. The largest company in the Philippines by sales looks set to expand further as it invests in major infrastructure projects. The stock price has seen tremendous appreciation despite other local stocks seeing a downturn. This downturn has been caused by general anxiety about developing markets and protectionist policies from the Trump administration.
PFP PSKXF SMCP1 PF SMPFY PFP2 SMGBY SMGBF SMC2B HRL SMC2A SMC SMC2D SMC2C SMC2F SMC2E PHSXY PSE GSMI SMPFF
Exchange traded funds ("ETFs") that focus on companies that pay dividends, follow a wide variety of stock selection strategies. These range from simply selecting the highest yielding dividend paying stocks in the market to sophisticated proprietary strategies with multiple selection criteria. We analyze the investment results of the most popular U.S. listed ETFs to determine which strategies work.
VIG ABT MTSI UNP O OPRF ABT MCY HRL SDY VALU ABM TRI MSFT
Whenever the stock market marches higher, it pushes the prices of many companies higher along with it. But as investors bid up good and bad businesses alike, that can make it hard to discern which companies are the best dividend stocks for long-term investors.
LOW TXN ADP VZA HON AMT AAPL CCI CBS HON TMUSP CBS.A TMUS BDX COST CBS.WD MDT HRL S T ADPVV VZ CPV
The market managed to log a respectable win on Tuesday, though the 0.37% gain the S&P 500 logged yesterday wasn’t exactly rock-solid. There were almost as many falling stocks as rising stocks, and almost as much bearish volume as bullish volume. We’re not out of the woods yet, especially in light of the fact that September is generally a bearish month.
HRL GE GEC ALB GNE AMD INTC DIS
Hormel Foods Corporation (HRL - Free Report) has been a preferred investment pick, evident from the stock’s 14.7% increase in the past three months against the industry’s decline of 0.8%. Also, this meat products company hit a 52-week high of $41.69 yesterday, ultimately closing at $41.52. That said, let’s take a peek at some of the factors aiding this Zacks Rank #3 (Hold) company and also delve into some of the aspects that pose threats.
HRL PF CHEF
The S&P finished the trading day (6th September) at 2,878 but dropped to 2,868 in intra-day trading. As mentioned in previous articles, we tend to sell our swing trade positions as close as we can to intermediate tops. This time around (although we were early), we primarily sold our TQQQ position a few weeks, which is leveraged NASDAQ ETF primarily associated with non-financial firms.
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to HRL / Hormel Foods Corp. on message board site Silicon Investor.
|Herley Industries (HRLY)||Herley Industries (HRLY)||Herley Industries (HRLY)|
as of ET